BioPharmX Corp·4

Dec 12, 5:37 PM ET

BioPharmX Corp 4

4 · BioPharmX Corp · Filed Dec 12, 2016

Insider Transaction Report

Form 4
Period: 2016-12-08
Transactions
  • Award

    Option to purchase common stock

    2016-12-08$0.42/sh+150,000$63,000150,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
    Exercise: $0.42From: 2017-01-08Exp: 2026-12-08Common stock (150,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 12 months with the first vesting starting on 1/8/17.
  • [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT